JSS AHER had organised the conference in association with the International Applied Biologists Association (IABA).

UCART22 Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025; Orphan Drug Designation (ODD) and Rare ...

Theratechnologies Inc. ("Theratechnologies" or the "Company") , a commercial-stage biopharmaceutical company, today presented data highlighting the limitations of using body mass index (BMI) alone in ...

The inaugural conference for the Centre for Microbial Interactions at Norwich Research Park brought together one of the world’s largest ...

The inaugural conference for the Centre for Microbial Interactions at Norwich Research Park brought together one of the world ...

Q4 2024 Earnings Call Transcript March 4, 2025 Wave Life Sciences Ltd. beats earnings expectations. Reported EPS is $0.17, expectations were $-0.17. Operator: Good morning and welcome to the Wave Life ...

However, over the past two decades, the country has also invested in building a competitive biotechnology sector. Given its limited domestic market but strong infrastructure in manufacturing, research ...

However, the makers have doubled the excitement with a brand-new poster taking the internet by storm. The latest poster came ahead of the much-anticipated "raw statement" release on March 3.

As these technologies continue to develop, they will likely bring about significant improvements in health, the environment, and beyond, highlighting the ever-increasing importance of biotechnology in ...

Renowned artist Matt Ferguson has also designed a brand-new poster to mark the re-release, which you can check out below. For many fans, Revenge of the Sith stands out as the best film of the ...

Immunic Presents Key Vidofludimus Calcium Data at the ACTRIMS Forum 2025, Highlighting Its Potential in Multiple Sclerosis – Vidofludimus Calcium’s Activation of Nurr1 Reduces ...

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced ...